annual cash & cash equivalents:
$169.51M+$39.72M(+30.60%)Summary
- As of today (June 17, 2025), GPCR annual cash & cash equivalents is $169.51 million, with the most recent change of +$39.72 million (+30.60%) on December 31, 2024.
- During the last 3 years, GPCR annual cash & cash equivalents has risen by +$64.20 million (+60.97%).
- GPCR annual cash & cash equivalents is now at all-time high.
Performance
GPCR Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$152.12M-$17.39M(-10.26%)Summary
- As of today (June 17, 2025), GPCR quarterly cash & cash equivalents is $152.12 million, with the most recent change of -$17.39 million (-10.26%) on March 31, 2025.
- Over the past year, GPCR quarterly cash & cash equivalents has increased by +$54.29 million (+55.49%).
- GPCR quarterly cash & cash equivalents is now -60.14% below its all-time high of $381.63 million, reached on June 30, 2024.
Performance
GPCR quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GPCR Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.6% | +55.5% |
| 3 y3 years | +61.0% | - |
| 5 y5 years | +936.6% | +44.5% |
GPCR Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +549.7% | -60.1% | +483.1% |
| 5 y | 5-year | at high | +936.6% | -60.1% | +483.1% |
| alltime | all time | at high | +936.6% | -60.1% | +483.1% |
GPCR Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $152.12M(-10.3%) |
| Dec 2024 | $169.51M(+30.6%) | $169.51M(-1.5%) |
| Sep 2024 | - | $172.13M(-54.9%) |
| Jun 2024 | - | $381.63M(+290.1%) |
| Mar 2024 | - | $97.83M(-24.6%) |
| Dec 2023 | $129.79M | $129.79M(+156.3%) |
| Sep 2023 | - | $50.64M(+24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $40.59M(-67.9%) |
| Mar 2023 | - | $126.49M(+384.8%) |
| Dec 2022 | $26.09M(-75.2%) | $26.09M(-7.1%) |
| Sep 2022 | - | $28.09M(-73.3%) |
| Dec 2021 | $105.31M(+544.0%) | - |
| Dec 2021 | - | $105.31M |
| Dec 2020 | $16.35M | - |
FAQ
- What is Structure Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Structure Therapeutics?
- What is Structure Therapeutics annual cash & cash equivalents year-on-year change?
- What is Structure Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Structure Therapeutics?
- What is Structure Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Structure Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of GPCR is $169.51M
What is the all time high annual cash & cash equivalents for Structure Therapeutics?
Structure Therapeutics all-time high annual cash & cash equivalents is $169.51M
What is Structure Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, GPCR annual cash & cash equivalents has changed by +$39.72M (+30.60%)
What is Structure Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GPCR is $152.12M
What is the all time high quarterly cash & cash equivalents for Structure Therapeutics?
Structure Therapeutics all-time high quarterly cash & cash equivalents is $381.63M
What is Structure Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, GPCR quarterly cash & cash equivalents has changed by +$54.29M (+55.49%)